百济神州：汪来担任公司总裁以及全球研发负责人

Core Viewpoint - The company announced the appointment of Dr. Wang Lai as President and Global Head of R&D, effective immediately, to oversee R&D, business development, and alliance management functions [1] Group 1: Appointment Details - Dr. Wang Lai has been with the company since 2011, holding various leadership roles in R&D, and has served as the Global Head of R&D since April 2021 [1] - Prior to joining the company, Dr. Wang worked as a Research Director at Joyant Pharmaceuticals in Dallas, Texas, from 2008 to 2011 [1] - Dr. Wang holds a Bachelor of Science degree from Fudan University (1996) and a Ph.D. from the University of Texas Health Science Center at San Antonio (2001) [1]